B6J.B6-Tg(Kit*D814V)1Roer/Ph

Status

Available to order

EMMA IDEM:11567
Citation informationRRID:IMSR_EM:11567 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6J.B6-Tg(Kit*D814V)1Roer/Ph
Alternative nameB6 Tg(Kit*D814V)1Roer
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Kit*D814V)1Roer
Gene/Transgene symbolTg(Kit*D814V)1Roer

Information from provider

ProviderAxel Roers
Provider affiliationInstitute for Immunology, Medical Faculty TU Dresden
Genetic informationMutation details: This transgene consists of a modified mouse BAC clone RP23-274L11 which contains the entire Kit locus. The Kit locus in the BAC was modified by the insertion of a floxed stop cassette into intron 1 and the insertion of an A to T point mutation in exon 17 resulting in an aspartic acid to valine mutation at position 814. This mutation is homologous to the D816V mutation in humans. This line carries 5-6 copies of the transgene.
Phenotypic informationHomozygous:
No phenotype without cre recombinase expression. Homozygous Tg(Kit*D814V)1Roer mice are viable and fertile.

Heterozygous:
No phenotype without cre recombinase expression. Hemizygous Tg(Kit*D814V)1Roer mice are viable and fertile. Mating of Tg(Kit*D814V)1Roer to Mx1-cre leads to mastocytosis in skin and internal organs, pre B lymphocyte neoplasia and colitis. Mating of Tg(Kit*D814V)1Roer to Cd19-cre results in pre B lymphocyte neoplasia. Mating of Tg(Kit*D814V)1Roer to Cma1-cre (Mcpt5-cre) leads to mastocytosis and colitis.
Breeding historyPronucleus injection into C57BL/6 oocytes yielded several founder lines and was performed in 2006. Tg1 founder line was constantly backcrossed to C57BL/6 since 2006 (>20 generations). Tg(Kit*D814V)1Roer hemizygous parents are currently bred to each other. C57BL/6JRj from Janvier was used for backcrossing since 2010.
References
  • Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.;Gerbaulet Alexander, Wickenhauser Claudia, Scholten Julia, Peschke Katrin, Drube Sebastian, Horny Hans-Peter, Kamradt Thomas, Naumann Ronald, Müller Werner, Krieg Thomas, Waskow Claudia, Hartmann Karin, Roers Axel, ;2011;Blood;117;2012-21; 21148330
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitute of Molecular Genetics, Prague, Czech Republic
Animals used for archivinghomozygous C57BL/6J males

Literature references

  • Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.;Gerbaulet Alexander, Wickenhauser Claudia, Scholten Julia, Peschke Katrin, Drube Sebastian, Horny Hans-Peter, Kamradt Thomas, Naumann Ronald, Müller Werner, Krieg Thomas, Waskow Claudia, Hartmann Karin, Roers Axel, ;2011;Blood;117;2012-21; 21148330

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).